In utero treatment of congenital cytomegalovirus infection with valganciclovir: an observational study on safety and effectiveness.

Tertiary prevention by valganciclovir appears to be well tolerated for both fetus and mother. However, more extensive trials accompanied by long-term follow-up are needed.